Dialysis News and Research

Latest Dialysis News and Research

MEDIHONEY dressings effective in treating chronic wounds in children

Chronic, non-healing wounds can be a serious problem for children as many currently available treatment modalities can be too harsh or toxic. At the 2010 Symposium on Advanced Wound Care (SAWC) and the Wound Healing Society (WHS), an international conference drawing clinicians from all over the globe which was held April 17-20 in Orlando, two clinicians presented case series illustrating the benefits of MEDIHONEY® dressings for this challenging patient population.

17 Apr 2010

Extracorporeal liver support therapy valued as detoxification treatment option for patients with cirrhosis

Results from two studies presented today at the International Liver CongressTM 2010 have shown that treatment with extracorporeal devices may not confer a survival advantage for severe liver failure patients, despite positive dialysis effects. However, results among a small sub-group of patients show promise.

17 Apr 2010

Data from Phase 2 clinical trials of Hematide/peginesatide presented at NKF Annual Meeting

Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced data from several post hoc analyses of Phase 2 clinical trials that evaluated Hematide/peginesatide in dialysis patients with anemia in chronic kidney disease. The data provide hypotheses for further investigation of this agent in anemia management in this patient population.

16 Apr 2010

USRC to acquire DCA

U.S. Renal Care, Inc., a privately-held leading provider of outpatient dialysis services, and Dialysis Corporation of America, a leading provider of outpatient kidney dialysis centers, announced today that they have entered into a definitive merger agreement for USRC to acquire DCA.

15 Apr 2010

BioTrends Research Group, NKF publish Special Report on patients with CKD

BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. -- both those on dialysis and those with mid-late stage chronic kidney disease -- completed a survey about living with CKD.

13 Apr 2010

Genes influence chronic kidney disease risk: Research

A team of researchers from the United States and Europe has identified more than a dozen genes that may play a role in the etiology of common forms of kidney disease. The team, known as the CKDGen Consortium, examined common variations in DNA sequences in more than 65,000 individuals of European descent. Common variations in several genes were found to be more frequent among people with poor kidney function or chronic kidney disease than in those with normal kidney function.

13 Apr 2010

Medinox, Orient Europharma form partnering agreement for NOX-100 anti-hypotensive drug

Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.

12 Apr 2010

Kidney disease genes discovered

Chronic kidney disease affects one in 10 adults and can severely damage a patient’s quality of life over years. This disease is linked to advanced age with one in five men and one in four women aged between 65 and 74 developing some degree of kidney damage.

12 Apr 2010

Renal specialist says Dr Patel’s patient was too frail for surgery

In the ongoing trial of Dr Jayant Patel, Dr Peter Miach, a renal specialist, gave evidence before the Supreme Court in Brisbane. Dr Miach said the patient James Phillips had too many other problems and he would not have recommended surgery for him in his frail state.

12 Apr 2010

DealSearchOnline.com announces $72.3B committed to fund 291 managed care mergers and acquisitions

More than $72.3 billion was committed to fund 291 managed care mergers and acquisitions announced during the 10-year period ended December 31, 2009, according to DealSearchOnline.com. UnitedHealth Group was the acquirer in 10 of the top 25 managed care mergers and acquisitions announced during 10-year period ended December 31, 2009.

7 Apr 2010

Nephros' 2009 product revenues up 81%

Nephros, Inc. announced today financial results for the twelve month period ended December 31, 2009.

3 Apr 2010

Amherst Dialysis staff honored with End Stage Renal Disease Patient Safety Improvement Award

Laura Simms has spent 12 hours a week receiving hemodialysis treatment since last fall, when her kidneys failed as a result of high blood pressure. The 50-year-old Monroe resident says the staff at University of Virginia Health System's Amherst Dialysis clinic have become like family to her.

2 Apr 2010

Hepatitis C infected donor kidneys thrown away despite urgent need

More than half of donor kidneys in the United State infected with hepatitis C are thrown away, despite the need among hepatitis C patients who may die waiting for an infection-free organ, Johns Hopkins research suggests.

2 Apr 2010

APP, Fresenius Kabi and sanofi-aventis sign license and settlement agreements

Fresenius Kabi Pharmaceuticals Holding, Inc.,, the parent company of APP Pharmaceuticals, Inc., announced today that APP and other Fresenius Kabi companies have entered into license and settlement agreements with sanofi-aventis covering patents that apply to Eloxatin® (oxaliplatin injection and oxaliplatin for injection).

2 Apr 2010

New index developed to determine risk of death in patients with end-stage kidney disease

A new clinical prediction index has been developed to determine the risk of death in patients with end-stage kidney disease considering transplantation, states a Research article in CMAJ.

1 Apr 2010

Hemosphere completes $9.3M venture capital financing

Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.

1 Apr 2010

NKF 2010 Spring Clinical Meeting: Multiple posters on Hematide/peginesatide to be presented

Affymax, Inc. and Takeda Pharmaceuticals Global Research & Development Center, Inc., U.S., today announced multiple posters on Hematide™/peginesatide have been accepted for presentation at the National Kidney Foundation (NKF) 2010 Spring Clinical Meeting taking place April 13-17, 2010 in Orlando, Florida. Hematide is an investigational agent for the treatment of anemia in chronic renal failure (also referred to as renal anemia).

31 Mar 2010

Bayshore Home Health deploys WinMagic's SecureDoc full-disk encryption software

Bayshore Home Health, Canada's largest provider of home and community health care services, is installing WinMagic's SecureDoc full-disk encryption software on all laptops and tablets used by the company, including those utilized by clinical managers and nurses.

30 Mar 2010

MedBuild receives MBI's 2010 Awards of Distinction for Nash Memorial Hospital Project

Modular Building Institute has named MedBuild, a healthcare division of ModSpace, first-place winner for their 2010 Awards of Distinction. MBI gave MedBuild top honors in its permanent healthcare category for its construction of the patient-ready imaging suite at Nash General Hospital in Rocky Mount, N.C.

30 Mar 2010

Methuselah Foundation, Silverstone Solutions partner to create online NewOrgan Registry

Methuselah Foundation, a medical non-profit dedicated to extending healthy human life, today announced that it has made an investment in Silverstone Solutions, Inc., a San Francisco-based innovator in life science computing.

27 Mar 2010

Dialysis News and Research

Latest Dialysis News and Research

MEDIHONEY dressings effective in treating chronic wounds in children

Extracorporeal liver support therapy valued as detoxification treatment option for patients with cirrhosis

Data from Phase 2 clinical trials of Hematide/peginesatide presented at NKF Annual Meeting

USRC to acquire DCA

BioTrends Research Group, NKF publish Special Report on patients with CKD

Genes influence chronic kidney disease risk: Research

Medinox, Orient Europharma form partnering agreement for NOX-100 anti-hypotensive drug

Kidney disease genes discovered

Renal specialist says Dr Patel’s patient was too frail for surgery

DealSearchOnline.com announces $72.3B committed to fund 291 managed care mergers and acquisitions

Nephros' 2009 product revenues up 81%

Amherst Dialysis staff honored with End Stage Renal Disease Patient Safety Improvement Award

Hepatitis C infected donor kidneys thrown away despite urgent need

APP, Fresenius Kabi and sanofi-aventis sign license and settlement agreements

New index developed to determine risk of death in patients with end-stage kidney disease

Hemosphere completes $9.3M venture capital financing

NKF 2010 Spring Clinical Meeting: Multiple posters on Hematide/peginesatide to be presented

Bayshore Home Health deploys WinMagic's SecureDoc full-disk encryption software

MedBuild receives MBI's 2010 Awards of Distinction for Nash Memorial Hospital Project

Methuselah Foundation, Silverstone Solutions partner to create online NewOrgan Registry

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in